Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016–2022
Deus Lukoye, Gail Gustavson, Proscovia Namuwenge, Simon Muchuro, Estella Birabwa, Seyoum Dejene, Julius Ssempiira, Julius N. Kalamya, Steven Baveewo, Odile Ferroussier‐Davis, Lisa Mills, Emilio Dirlikov, Lisa Nelson, Stavia Turyahabwe
Abstract
During October 2016-March 2022, Uganda increased tuberculosis (TB) preventive therapy coverage among persons living with HIV from 0.6% to 88.8%. TB notification rates increased from 881.1 to 972.5 per 100,000 persons living with HIV. Timely TB screening, diagnosis, and earlier treatment should remain high priorities for TB/HIV prevention programming.
Topics & Concepts
TuberculosisMedicineHuman immunodeficiency virus (HIV)Environmental healthVirologyAntiretroviral therapyImmunologyFamily medicineIntensive care medicineViral loadPathologyTuberculosis Research and EpidemiologyPneumocystis jirovecii pneumonia detection and treatmentDiagnosis and treatment of tuberculosis